MedTrace Logo

Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD)

NCT03375294 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2020-07-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to understand nitrous oxide effects in post traumatic stress disorder (PTSD)

Conditions

  • Post Traumatic Stress Disorder

Interventions

DRUG

Nitrous Oxide

One hour inhalation of 50% nitrous oxide, an odorless, colorless gas FDA approved as an induction agent for dental sedation

Sponsors & Collaborators

Principal Investigators

  • Carolyn Rodriguez, MD, PhD · Stanford University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-07-31
Completion
2020-04-05
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03375294 on ClinicalTrials.gov